METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
Cited by 141
Related Papers
Understanding the gut microbiota and sarcopenia: a systematic review
|Journal of Cachexia Sarcopenia and Muscle|2021|340
Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid
|Nature Microbiology|2023|226
Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis
|Oncogene|2013|129
microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer
|Molecular Cancer|2014|128